Allie Strickler

Michael F. Press, M.D., Ph.D., shed light on the role of the receptor in breast cancer in a presentation during the 2017 Miami Breast Cancer Conference.

New guidelines may result in a small percentage of patients with breast cancer being misclassified and not receiving proper treatment, Michael F. Press, M.D., Ph.D., says.

Lowering weight may lead to lowering the risk for developing endometrial cancer, according to recent findings.

Adding hormone therapy to radiation therapy after surgery showed significant survival improvements in a recent study involving men with recurrent prostate cancer.

A racial disparity exists among patients who die from cervical cancer, according to the results from a recent study.

Diagnostic laparoscopy can play a role in predicting surgery outcomes for patients with ovarian cancer.

Findings from a recent study lay out the groundwork to help identify men who are at higher risk from dying of prostate cancer.

From stigma to convenience, there are many reasons why people do not get the HPV vaccine, although it can prevent some types of cancer. Lois Ramondetta, M.D., discusses updated recommendations and hopes for getting more young people vaccinated.

A new subtype of cervical cancer was found that does not express the HPV oncogene.

Roy Herbst, M.D., Ph.D., spoke with CURE about the future of Keytruda, and immunotherapy in general, to treat lung cancer.

A recent study found that there has been a sharp decrease in the percentage of men who are being treated for prostate cancer.

The results of a recent study showed that a wait-and-watch approach may be appropriate for patients with rectal cancer.

There is a need to find biomarkers that may help predict recurrence in HPV+ oropharyngeal cancer, says Matthew E. Spector, M.D.

Brian J. Czerniecki, M.D., Ph.D., discusses a promising vaccine for certain patients with breast cancer.

Dimosthenis Andreou, M.D., discussed the Euro-EWING99 trial with CURE.

Finding new biomarkers should be the top priority in ovarian cancer research, Maurie Markman, M.D., says.

Over-the-counter pain management drugs may negatively affect the outcomes of patients with endometrial cancer, a recent study found.

Expedited surgery for patients who are recently diagnosed with endometrial cancer may actually lead to increased mortality, according to a recent study.

Computed-tomography (CT)-planned high-dose-rate (HDR) intracavitary brachytherapy (BT) showed excellent local control for patients with stage 1 or 2 cervical cancer, according to a recent study.

The treatment landscape of bladder cancer drastically changed this spring with the approval of an immunotherapy agent, and will continue to shift in the months and years to come.

Keytruda improved quality of life for patients with lung cancer in a recent trial.

With the addition of PARP inhibitors, as well as new agents on the horizon, the treatment landscape of gynecologic cancers is progressing.

Everett Vokes, M.D. discusses what the future of immunotherapy might mean for patients with head and neck cancer.

Opdivo had positive results in patients with advanced bladder cancer according to findings from the CheckMate-275 trial.

A recent study found a correlation between frequent cervical cancer screenings and decreased mortality.

Women with stage 1 endometrioid adenocarcinoma of the uterus showed improved survival with vaginal brachytherapy (VB), according to a large database analysis published in the journal Cancer.

A recent study showed a correlation between higher body mass index and survival in some patients with kidney cancer.

Neoadjuvant chemotherapy is the best option for some patients with ovarian cancer, according to a recent report.

ASCO and SGO just made new guidelines stating that neoadjuvant chemotherapy is the best first-line treatment for some women with ovarian cancer.

Brexit is bound to have big implications in the field of cancer care.